mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.03 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.03 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.098 |
0.03 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |